Hain Celestial To Participate in Upcoming Investor Conferences |
Globe Newswire |
11/13 |
16:15 |
Voting Rights and Shares Capital of the Company |
Globe Newswire |
11/13 |
16:15 |
SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
11/13 |
16:15 |
Victoria’s Secret & Co. Invites You to Listen to the Third Quarter 2024 Earnings Call Webcast |
Globe Newswire |
11/13 |
16:15 |
INE Security Endorses Formal Assessments in IT/IS Training |
Globe Newswire |
11/13 |
16:14 |
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets |
Globe Newswire |
11/13 |
16:14 |
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Healthcare Company Inc. (ACHC) |
Globe Newswire |
11/13 |
16:11 |
Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates |
Globe Newswire |
11/13 |
16:10 |
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 |
Globe Newswire |
11/13 |
16:10 |
Alpine Income Property Trust Announces Changes to Board of Directors |
Globe Newswire |
11/13 |
16:10 |
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Entero Therapeutics, Inc. (Nasdaq - ENTO), Pulmatrix, Inc. (Nasdaq – PULM), Liberty Broadband Corporation (Nasdaq – LBRDA, LBRDK, LBRDP), Manitex International, Inc. (Nasdaq - MNTX) |
Globe Newswire |
11/13 |
16:09 |
Trump promises to turn Washington upside down. He's being welcomed back anyway |
AP Online |
11/13 |
16:09 |
Lulus Reports Third Quarter 2024 Results |
Globe Newswire |
11/13 |
16:07 |
Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements |
Globe Newswire |
11/13 |
16:05 |
StoneX Group Inc. to Announce 2024 Fiscal Fourth Quarter Earnings on November 19, 2024 |
Globe Newswire |
11/13 |
16:05 |
NextNav Inc. Reports Third Quarter 2024 Results |
Globe Newswire |
11/13 |
16:05 |
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 |
Globe Newswire |
11/13 |
16:05 |
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights |
Globe Newswire |
11/13 |
16:05 |
The Oncology Institute Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:05 |
Roadzen Reports Fiscal Second Quarter and First Half FY2025 Financial Results |
Globe Newswire |
11/13 |
16:05 |
Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates |
Globe Newswire |
11/13 |
16:05 |
OptimizeRx Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:05 |
Glass House Brands Reports Record Setting Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:05 |
4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones |
Globe Newswire |
11/13 |
16:05 |
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing |
Globe Newswire |
11/13 |
16:05 |